November 15, 2018
Non-Alcoholic Fatty Liver Disease for the Primary Care Clinician
Non-Alcoholic Fatty Liver Disease (NAFLD) is hepatic steatosis on imaging or histology in the absence of other causes of steatosis. It is frequently diagnosed when the patient is found to have an elevation in transaminase levels or as an incidental finding on imaging. It is estimated that the prevalence of NAFLD in the United States is 30%. Approximately 10-30% of patients with NAFLD develop non-alcoholic steatohepatitis which is associated with increased mortality due to the development of cirrhosis and hepatocellular carcinoma. In this webinar, Dr. Ethan Bortniker, M.D., will review the natural history of Non-Alcoholic Fatty Liver Disease; define the epidemiology and recognize the risk factors of Non-Alcoholic Fatty Liver Disease that may present in primary care; and identify the various diagnostic and management options available to patients with Non-Alcoholic Fatty Liver Disease.
November 15, 2018
3:00PM - 4:00PM EST
CME CREDITS: 1.0 (SEE BELOW)
FACULTY: ETHAN BORTNIKER, MD
By the end of the event, participants should:
1. Become familiar with the natural history of Non-Alcoholic Fatty Liver Disease
2. Define the epidemiology and recognize the risk factors of Non-Alcoholic Fatty Liver Disease that may present in primary care
3. Review the various diagnostic and management options available to patients with Non-Alcoholic Fatty Liver Disease
Ethan Bortniker, MD
Assistant Professor of Medicine Gastroentrology, UConn Health
Director of Colorectal Clinical Research, UConn Health
Dr. Ethan Bortniker is an Assistant Professor of Medicine and Director of Colorectal Clinical Research at UConn Health. He is a graduate of Boston University School of Medicine. He completed his internal medicine residency at Boston University Medical Center and Gastroenterology fellowship training at the UConn School of Medicine. Dr. Bortniker is board-certified in internal medicine and gastroenterology. His areas of expertise are colorectal cancer prevention and motility disorders, and research interests include fecal microbiome and cancers of the GI tract.
J. Nwando Olayiwola, MD, MPH, FAAFP
Anna Potapov, MD, MPH, MBA
Marc E. Walker, MD, MBA
Pooja Mittal, DO
This lecture will be conducted as a one-hour live webinar. Registration is free. Participants will submit a survey at the end of the session to claim CME credit.
AAFP CREDIT STATEMENT
This Live series activity, Optimizing Management of Common Specialty Conditions in the Primary Care Setting, from 07/01/2018 - 07/01/2019, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Each webinar in the series is approved for 1.0 AAFP Prescribed credits.
AMA/AAFP Equivalency: AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
This Live series activity is eligible for Continuing Education credit from the American Association of Physician Assistants (AAPA) and the American Association of Nurse Practitioners (AANP). Physician Assistants (PAs) and Nurse Practitioners (NPs) may claim AMA PRA Category 1 equivalent credits per webinar based on their participation.